On October 31, 2024, Davis Polk partners James Lin and Steve Wang will be among the speakers at the annual BioCentury-BayHelix China Healthcare Summit. The summit aims to help executives…
Davis Polk was recognized with three awards at the 2024 Asia Legal Awards, presented by Law.com International. The awards recognize the most important transactions and cases with the most…
Davis Polk and the firm’s lawyers are shortlisted for thirteen awards for the 2024 Asia Legal Awards, presented by Law.com International. The awards recognize the most important…
On November 2, 2023, Davis Polk partners James Lin and Steve Wang will be among the speakers at the 10th annual BioCentury-BayHelix China Healthcare Summit. James and Steve will speak…
On October 30, 2023, Davis Polk partner James Lin will be among the speakers at the 2023 Vietnam Venture Summit. James will speak on the “Public vs. Private Markets: the Changing Investment…
On October 20, 2023, Davis Polk partner James Lin will be among the speakers at SS&C Intralinks and Workiva’s jointly hosted “Mapping your Strategic Roadmap: An IPO and M&A Outlook”…
On November 15, 2022, Davis Polk partners James Lin and Steve Wang will be among the speakers at BioCentury and BayHelix’s East-West BioPharma Summit. James and Steve will chair the “3rd…
On August 24, 2021, Davis Polk partner James Lin will be among the speakers at Asia Society Northern California’s “Executive Roundtable on Chinese Government Regulations on IPOs.” Topics…
Davis Polk partner James Lin was quoted in a recent Law.com International article discussing how U.S. firms can benefit from the strong pipeline of Asia-focused SPACs. “Even before the wave…
Davis Polk partner James Lin was quoted in a recent Asian Legal Business article discussing the resilience of Hong Kong capital markets amid the uncertainty of the COVID-19 pandemic. Lin…
